secwatch.observer — SEC 8-K summary
======================================

Issuer:     Greenwich LifeSciences, Inc. (GLSI)
CIK:        0001799788
Form:       8-K
Filed at:   2024-12-19T23:59:59+00:00
Accession:  0001493152-24-050777
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Greenwich LifeSciences holds 2024 annual meeting; all director nominees elected, equity plan amendment approved
--------------------------------------------------------------------------------

- All five director nominees elected with majority support; no votes against, only abstentions and broker non-votes.
- Ratification of RBSM as independent auditor for FY2024 approved: 9,224,694 for, 10,077 against, 2,644 abstain.
- Amendment to 2019 Equity Incentive Plan to increase reserved shares from 1.5M to 4.0M approved: 8,067,672 for, 164,730 against.
- Total shares represented at meeting: 12,848,165, constituting a quorum.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1799788/000149315224050777/0001493152-24-050777-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1799788/000149315224050777/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-050777

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer